Grand Central Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
1,671
+132
+9% +$134K 1.14% 24
2025
Q4
$1.65M Buy
+1,539
New +$1.47M 1.2% 25

Other funds holding LLY

Grand Central Investment Group's LLY Position: Q1 2026 in Review

Grand Central Investment Group increased its Eli Lilly (LLY) stake by 8.6% in Q1 2026, buying an estimated $134K and bringing the position to 1,671 shares worth $1.54M. The position accounts for 1.14% of the portfolio, ranked #24.

Grand Central Investment Group first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.65M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Grand Central Investment Group held 1,671 shares of Eli Lilly worth $1.54M as of Q1 2026.
  • Grand Central Investment Group bought 132 Eli Lilly shares in Q1 2026, an estimated $134K.
  • Eli Lilly made up 1.14% of Grand Central Investment Group's portfolio in Q1 2026, its #24 holding.
  • Grand Central Investment Group first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Grand Central Investment Group's Eli Lilly position peaked at $1.65M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Grand Central Investment Group's 13F filing for Q1 2026, filed 23 Apr 2026.